PEPTIDE_CODEX

← All peptides

PC-028 · metabolic · rg3

RG3

Ginsenoside Rg3

Also: Rg3

human trialanimal studyin vitro

A ginsenoside compound derived from Panax ginseng that has gained attention in the peptide community for its metabolic and anti-cancer properties. While technically a triterpenoid saponin rather than a peptide, it's widely discussed alongside peptide protocols for its complementary fat-loss and anti-inflammatory effects.

Inhibits angiogenesis in tumors, modulates AMPK signaling for metabolic benefits, reduces NF-κB mediated inflammation, and enhances insulin sensitivity. Inhibits adipocyte differentiation and promotes brown adipose tissue activation for thermogenesis.

  • → Fat loss
  • → Anti-inflammatory
  • → Metabolic support
  • → Anti-cancer adjuvant
  • → Insulin sensitivity
  • · GI upset (oral)
  • · Insomnia
  • · Headache

Mechanism of Action

Inhibits angiogenesis in tumors, modulates AMPK signaling for metabolic benefits, reduces NF-κB mediated inflammation, and enhances insulin sensitivity. Inhibits adipocyte differentiation and promotes brown adipose tissue activation for thermogenesis.

Common Uses

Fat lossAnti-inflammatoryMetabolic supportAnti-cancer adjuvantInsulin sensitivity

Dosage & Pharmacology

DOSAGE RANGE: 200-500 mcg daily (subcutaneous or oral)
HALF-LIFE: ~4-6 hours
Dosage information is for research reference only. Not a recommendation.

Known Side Effects

  • • GI upset (oral)
  • • Insomnia
  • • Headache

Legal Status

US:Available as supplement ingredient
UK:Available as supplement
EU:Available as supplement
AU:Available as supplement

Related Peptides

View all RG3 research on PubMed